Results show noninferiority to a full dose in preventing a recurrence of blood clots and an advantage when it comes to ...

Cancer blockbuster Revlimid has been suffering from generic competition, while Eliquis will be one of the first drugs to face ...

On top of noninferior efficacy, the trial showed patients had less bleeding with 2.5 mg vs 5.0 mg twice daily over 12 months.

Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s ...

Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.

Although new U.S. tariffs on Canada, Mexico, and China are putting pressure on markets, investors are shifting toward defensive positions amid economic uncertainty.

DEAR DR. ROACH: I am 82 and take gabapentin for arthritis, but my niece takes it for anxiety. What is gabapentin all about? -- J.M. ANSWER: Gabapentin was originally approved as a drug to control ...

Taho Pharmaceuticals’s apixaban-based oral dissolving strips ... now plans to use these results to push ahead with a new drug application (NDA) and a marketing authorisation application (MAA ...

Most minor bleeds were manageable and didn't require stopping the drug. More information: Tsung-Yu Ko et al, A randomized controlled trial evaluated the efficacy and safety of apixaban for ...